BillionToOne, Inc (BLLN) Diversifiers

Equity · Currency in USD · Last updated Jun 6, 2026

BillionToOne, Inc. develops a molecular counting platform that detects and measures DNA molecules at the single-count level to enhance disease detection, offering tests such as UNITY Complete for non-invasive prenatal screening and Northstar Select and Northstar Response for cancer mutation analysis and monitoring.

Looking to balance out your exposure to BLLN? The ETFs below have the lowest correlation with BLLN — they tend to move on their own, which can help reduce risk when BLLN drops. The stock ideas table highlights individual companies that behave independently from BLLN.

No Diversifiers Found for BLLN

We do not have enough correlation history to rank diversifiers for this symbol yet.

Diversification Analysis

Build a portfolio that complements BLLN

Add BLLN to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.

Analyze a portfolio with BLLN